Biogen - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeBiogen
Biogen logo

Biogen

0 followers

BIIB

Performance

About Biogen

Biogen is a global biotechnology company focused on discovering, developing, and delivering innovative medicines for serious neurological and rare diseases such as multiple sclerosis, Alzheimer's disease, ALS, spinal muscular atrophy, and lupus. Leveraging deep expertise in human biology and multiple therapeutic modalities, Biogen advances first‑in‑class treatments through extensive R&D, clinical trials, and early‑access programs, while emphasizing health equity, sustainability, and patient advocacy across its worldwide operations.

Recent News

Recent Deals

Key Team Members

Rachid Izzar

Head of Global Product Strategy & Commercialization

Susan H. Alexander

Chief Legal Officer

Ginger Gregory, Ph.D.

Chief Human Resources Officer

Nicole Murphy

Head of Pharmaceutical Operations and Technology

Christopher A. Viehbacher

President and Chief Executive Officer

Key Facts

HQ Location

Cambridge, United States

Founded

1978

Employees

5K-10K

Status

Public

Website

https://biogen.com